This pipeline maps genes, with mutation or copy number alteration AND this alteration is highly correlated with mRNA expression, to pathways curated in the KEGG and BIOCARTA databases. It identifies pathways significantly enriched with these genes. The pipeline also identifies pathways significantly enriched with marker genes of each expression subtype of cancer.
genes with mutation: identified by the Mutation_Significance pipeline
genes with copy number alteration: identified by the CopyNumber_Gistic2 pipeline
correlation between copy number and mRNA expression: identified by the Correlate_CopyNumber_vs_mRNA pipeline
marker genes and expression subtypes: identified by the mRNAConsensusClustering pipeline
There are 102 genes with significant mutation (Q value <= 0.1) and 245 genes with significant copy number alteration (Q value <= 0.25). The identified marker genes (Q value <= 0.01 or within top 2000) are 2000 for subtype 1, 2000 for subtype 2, 2000 for subtype 3. Pathways significantly enriched with these genes (Q value <= 0.01) are identified :
0 pathways significantly enriched with genes with copy number alteration or mutation.
0 pathways significantly enriched with marker genes of gene expression subtype 1
11 pathways significantly enriched with marker genes of gene expression subtype 2
1 pathways significantly enriched with marker genes of gene expression subtype 3
Pathway | Nof Genes | Nof CNV_Mut | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 108 | 7 | 2 | 0.0019 | 0.38 |
KEGG_PARKINSONS_DISEASE | 130 | 7 | 2 | 0.0023 | 0.38 |
BIOCARTA_FAS_PATHWAY | 30 | 3 | 2.6 | 0.013 | 0.4 |
BIOCARTA_HIVNEF_PATHWAY | 56 | 4 | 2.1 | 0.013 | 0.4 |
BIOCARTA_TNFR1_PATHWAY | 29 | 3 | 2.6 | 0.012 | 0.4 |
MAP3K7,PIK3CD,NFKBIA,MAP2K2,ORC3L,PPP3CB,GSK3B
UBE2J1,COX6B1,VDAC2,NDUFS6,CASP9,SLC25A4,COX7A2
PRKDC,MAP3K7,PARP1
CASP9,PRKDC,NFKBIA,PARP1
PRKDC,MAP3K7,PARP1
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
BIOCARTA_GSK3_PATHWAY | 27 | 9 | 1.9 | 0.0003 | 0.025 |
KEGG_TRYPTOPHAN_METABOLISM | 40 | 11 | 1.7 | 0.0003 | 0.025 |
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 75 | 17 | 1.4 | 0.0002 | 0.025 |
BIOCARTA_G1_PATHWAY | 28 | 8 | 1.7 | 0.0022 | 0.058 |
BIOCARTA_WNT_PATHWAY | 26 | 8 | 1.8 | 0.0013 | 0.058 |
TOLLIP,TIRAP,PPP2CA,EHHADH,PIK3R1,FZD1,DVL1,GSK3B,EIF2AK2
EHHADH,IL4I1,OGDH,ACAT1,HAAO,AANAT,CAT,MAOB,INMT,ABP1,AOX1
AKT3,LYN,PIK3CD,CARD11,NFKBIA,CD72,RAC2,DAPP1,RASGRP3,SOS2,CHP,PIK3R3,PIK3R1,CR2,MALT1,VAV1,GSK3B
TGFB3,CDK6,ATR,CDK4,CDC25A,ATM,HDAC1,GSK3B
PPP2CA,MYC,GPI,CREBBP,FZD1,DVL1,HDAC1,GSK3B
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_OXIDATIVE_PHOSPHORYLATION | 133 | 31 | 1.6 | 0 | 0 |
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 59 | 16 | 1.8 | 0 | 0.0015 |
KEGG_CELL_CYCLE | 128 | 26 | 1.2 | 0 | 0.0018 |
KEGG_PARKINSONS_DISEASE | 130 | 24 | 1.3 | 0 | 0.0018 |
KEGG_PEROXISOME | 78 | 19 | 1.5 | 0 | 0.002 |
ATP6V1G3,ATP6V1B1,COX8A,PPA2,UQCRC2,COX11,UQCRFS1,ATP5L,NDUFS3,ATP5H,NDUFC2,ATP6V1H,NDUFA10,ATP6V1A,UQCRH,UQCRB,NDUFB5,NDUFB8,ATP6V1G2,NDUFB1,NDUFB2,TCIRG1,NDUFA5,COX7A2,NDUFA8,ATP5F1,NDUFA1,SDHB,SDHD,ATP5A1,ATP6V0A4
OCLN,TLR5,CTNNB1,RHOA,TUBB6,TUBA1A,TUBA1B,TUBB3,TUBA1C,LY96,ARPC1B,WASL,EZR,TUBA3C,TUBA3D,CD14
PTTG2,PTTG1,TGFB1,CCNA2,ESPL1,SKP1,ORC1L,ANAPC13,CHEK2,SMAD4,CDC20,CDC26,CDC14B,CDC45L,CDC7,CDC2,MCM4,MCM5,MCM6,BUB1B,BUB1,CDC25C,YWHAE,CDC25B,CCNB2,ORC3L
UBA7,COX8A,UQCRC2,UQCRFS1,NDUFS3,ATP5H,SLC25A4,NDUFC2,NDUFA10,UQCRH,UBB,UQCRB,NDUFB5,NDUFB8,NDUFB1,NDUFB2,NDUFA5,COX7A2,NDUFA8,ATP5F1,NDUFA1,SDHB,SDHD,ATP5A1
ACOX1,EHHADH,PRDX5,PEX3,ACOX3,PEX1,CAT,PECI,DHRS4,CROT,HACL1,ABCD1,ACSL1,PEX19,IDH1,PEX12,ACSL3,ACSL5,PHYH
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_SPLICEOSOME | 126 | 30 | 1.6 | 0 | 0 |
BIOCARTA_PTEN_PATHWAY | 18 | 6 | 1.9 | 0.0031 | 0.24 |
KEGG_PURINE_METABOLISM | 158 | 25 | 0.85 | 0.0022 | 0.24 |
KEGG_TRYPTOPHAN_METABOLISM | 40 | 9 | 1.4 | 0.0042 | 0.24 |
KEGG_ADHERENS_JUNCTION | 75 | 14 | 1.1 | 0.0035 | 0.24 |
SNRPD2,SMNDC1,SFRS4,RBM8A,LSM5,U2AF1,SNRPB,HNRNPC,BAT1,CCDC12,HSPA1L,HNRNPM,DDX46,HNRNPK,SNW1,DDX5,RBMX,SFRS2B,MAGOHB,PRPF3,SNRNP200,PRPF38B,TRA2B,SF3B3,PRPF19,SF3B1,DHX15,RBM25,SF3A1,RBM17
PDK2,FOXO3,PTEN,ITGB1,PTK2,ILK
ADCY4,SLC25A16,GMPR2,POLR2J2,NME7,NME4,ZNRD1,ENTPD5,ENTPD3,ENTPD2,AK1,GUCY2C,NT5M,GUCY1A3,PDE8A,NT5E,PDE10A,GMPS,GUCY1B3,POLR2J,POLA2,HPRT1,AK3L1,NPR2,APRT
EHHADH,WARS,HAAO,AANAT,MAOB,ACMSD,IDO1,ABP1,AOX1
WASF2,CTNNB1,CSNK2A2,PTPRM,ACTN4,CTNNA2,EP300,CTNND1,TCF7L2,PVRL4,YES1,CREBBP,CSNK2B,TJP1
Let genes with copy number alteration or mutation be query genes. Let marker genes of specific identified subtypes be query genes. The Enrichment is calculated as:
-
Enrichment = log2 (# of query genes in the pathway/# No of query genes) - log2 (# of genes in the pathway/# of human genes)
The statistical signficance of the pathways that are enriched with genes with copy number alteration or mutation, and the pathways that are enriched with markers genes of specific identified subtypes is measured by P value.
-
P value = Fisher exact P value
The Q value is for adjusting P value for multiple testing. A public available R package is used to calculate the Q value.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.